Drug Type Small molecule drug |
Synonyms Betamethasone/methocarbamol/indometacin, Indometacin/betamethasone/methocarbamol, Methocarbamol/indometacin/betamethasone |
Target |
Mechanism CA1 inhibitors(Carbonic anhydrase I inhibitors), COX inhibitors(Cyclooxygenases inhibitors), GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC19H16ClNO4 |
InChIKeyCGIGDMFJXJATDK-UHFFFAOYSA-N |
CAS Registry53-86-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Phase 3 | US | - | |
Pain | Phase 3 | - | - |